Plant 10

Being CDMO, Akums aims to support its Business partners by having a combined strategy of backward & forward integration. The purpose is to give a robust Risk mitigation plan for our associates/partners so that products keep moving consistently in the market in addition to introduction of new therapy areas / segments

Akums is pleased to announce its new acquisition, a subsidiary of Akums Group named as Akums Healthcare Ltd., Kotdwar.

The facility manufactures various dosage forms in General, β-Lactum Injectable and Penam and is located at the distance of 60km away from Haridwar and can be covered in 1.5 hrs.